Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation

Phosphorylation of Mdm2, in response to DNA damage, resulted in prevention of p53 degradation in the cytoplasm as well as reduction of its binding with monoclonal antibody (mAb) 2A10. Using a 15-mer phage-peptide library, we identified two 2A10-epitopes on human Mdm2 (hdm2): at positions 255–266 (LD...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2002-10, Vol.23 (10), p.1719-1725
Hauptverfasser: Balass, M., Kalef, E., Maya, R., Wilder, S., Oren, M., Katchalski-Katzir, E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1725
container_issue 10
container_start_page 1719
container_title Peptides (New York, N.Y. : 1980)
container_volume 23
creator Balass, M.
Kalef, E.
Maya, R.
Wilder, S.
Oren, M.
Katchalski-Katzir, E.
description Phosphorylation of Mdm2, in response to DNA damage, resulted in prevention of p53 degradation in the cytoplasm as well as reduction of its binding with monoclonal antibody (mAb) 2A10. Using a 15-mer phage-peptide library, we identified two 2A10-epitopes on human Mdm2 (hdm2): at positions 255–266 (LDSEDYSLSEEG) and 389–400 (QESDDYSQPSTS). Synthetic peptides corresponding to the above sites, inhibit the binding of mAb2A10 to Mdm2 with high (4.5×10 −9 M) and moderate affinity (1.1×10 −7 M), respectively. Phospho-derivatives of these peptides, and of single human Mdm2 mutations S260D or S395D resulted in a considerable reduction in their binding with mAb2A10. These results provide a molecular explanation for the observation that reactivity of Mdm2 with mAb2A10 is inhibited by phosphorylation.
doi_str_mv 10.1016/S0196-9781(02)00147-X
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72189099</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S019697810200147X</els_id><sourcerecordid>72189099</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-29aee8353bd228cd97fd844d3fc00dae5abf44295dc2ca8e3cc78cdcf2de6cbc3</originalsourceid><addsrcrecordid>eNqFkEtPWzEQRq2KCgLlJxR5hcrigh_3Ya8QivpAAnXRVsrOcsZjMErii-20or8ek0SwZDWLOd88DiGfOTvnjPcXvxjXfaMHxb8wccYYb4dm9oFMuBpk0_Fe75HJK3JADnN-YIy1rVb75IALqaTq1ITMpvc2WSiYwn9bQlzR6Gn5F-mIYwkOKY6hxBEzra1btxS1QhxTLBhWtNzbQq33CIWOnaQO75J1mzmfyEdvFxmPd_WI_Pn29ff0R3Pz8_v19OqmAdnz0ghtEZXs5NwJocDpwTvVtk56YMxZ7Ozct63QnQMBVqEEGCoGXjjsYQ7yiJxu59abHteYi1mGDLhY2BXGdTaD4EozrSvYbUFIMeeE3owpLG16MpyZF6Vmo9S8-DJMmI1SM6u5k92C9XyJ7i21c1iByy2A9c2_AZPJEHAF6EKqYoyL4Z0Vz3GsiKc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72189099</pqid></control><display><type>article</type><title>Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Balass, M. ; Kalef, E. ; Maya, R. ; Wilder, S. ; Oren, M. ; Katchalski-Katzir, E.</creator><creatorcontrib>Balass, M. ; Kalef, E. ; Maya, R. ; Wilder, S. ; Oren, M. ; Katchalski-Katzir, E.</creatorcontrib><description>Phosphorylation of Mdm2, in response to DNA damage, resulted in prevention of p53 degradation in the cytoplasm as well as reduction of its binding with monoclonal antibody (mAb) 2A10. Using a 15-mer phage-peptide library, we identified two 2A10-epitopes on human Mdm2 (hdm2): at positions 255–266 (LDSEDYSLSEEG) and 389–400 (QESDDYSQPSTS). Synthetic peptides corresponding to the above sites, inhibit the binding of mAb2A10 to Mdm2 with high (4.5×10 −9 M) and moderate affinity (1.1×10 −7 M), respectively. Phospho-derivatives of these peptides, and of single human Mdm2 mutations S260D or S395D resulted in a considerable reduction in their binding with mAb2A10. These results provide a molecular explanation for the observation that reactivity of Mdm2 with mAb2A10 is inhibited by phosphorylation.</description><identifier>ISSN: 0196-9781</identifier><identifier>EISSN: 1873-5169</identifier><identifier>DOI: 10.1016/S0196-9781(02)00147-X</identifier><identifier>PMID: 12383858</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anti-Mdm2 mAb2A10 ; Antibodies, Monoclonal - isolation &amp; purification ; Antibodies, Monoclonal - metabolism ; Antibodies, Monoclonal - pharmacology ; Binding Sites ; Epitope Mapping ; Epitopes ; Escherichia coli - genetics ; Glutathione Transferase - metabolism ; Humans ; Mutation ; Peptide epitopes ; Peptide Fragments - chemistry ; Peptide Fragments - genetics ; Peptide Fragments - immunology ; Peptide Fragments - metabolism ; Peptides - chemistry ; Phage-peptide library ; Phospho-peptides ; Phosphorylation ; Protein Binding ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins - immunology ; Proto-Oncogene Proteins - metabolism ; Recombinant Proteins - metabolism ; Serine - metabolism ; Tumor Suppressor Protein p53 - metabolism ; Tyrosine - metabolism</subject><ispartof>Peptides (New York, N.Y. : 1980), 2002-10, Vol.23 (10), p.1719-1725</ispartof><rights>2002 Elsevier Science Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-29aee8353bd228cd97fd844d3fc00dae5abf44295dc2ca8e3cc78cdcf2de6cbc3</citedby><cites>FETCH-LOGICAL-c361t-29aee8353bd228cd97fd844d3fc00dae5abf44295dc2ca8e3cc78cdcf2de6cbc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S019697810200147X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12383858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balass, M.</creatorcontrib><creatorcontrib>Kalef, E.</creatorcontrib><creatorcontrib>Maya, R.</creatorcontrib><creatorcontrib>Wilder, S.</creatorcontrib><creatorcontrib>Oren, M.</creatorcontrib><creatorcontrib>Katchalski-Katzir, E.</creatorcontrib><title>Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation</title><title>Peptides (New York, N.Y. : 1980)</title><addtitle>Peptides</addtitle><description>Phosphorylation of Mdm2, in response to DNA damage, resulted in prevention of p53 degradation in the cytoplasm as well as reduction of its binding with monoclonal antibody (mAb) 2A10. Using a 15-mer phage-peptide library, we identified two 2A10-epitopes on human Mdm2 (hdm2): at positions 255–266 (LDSEDYSLSEEG) and 389–400 (QESDDYSQPSTS). Synthetic peptides corresponding to the above sites, inhibit the binding of mAb2A10 to Mdm2 with high (4.5×10 −9 M) and moderate affinity (1.1×10 −7 M), respectively. Phospho-derivatives of these peptides, and of single human Mdm2 mutations S260D or S395D resulted in a considerable reduction in their binding with mAb2A10. These results provide a molecular explanation for the observation that reactivity of Mdm2 with mAb2A10 is inhibited by phosphorylation.</description><subject>Anti-Mdm2 mAb2A10</subject><subject>Antibodies, Monoclonal - isolation &amp; purification</subject><subject>Antibodies, Monoclonal - metabolism</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Binding Sites</subject><subject>Epitope Mapping</subject><subject>Epitopes</subject><subject>Escherichia coli - genetics</subject><subject>Glutathione Transferase - metabolism</subject><subject>Humans</subject><subject>Mutation</subject><subject>Peptide epitopes</subject><subject>Peptide Fragments - chemistry</subject><subject>Peptide Fragments - genetics</subject><subject>Peptide Fragments - immunology</subject><subject>Peptide Fragments - metabolism</subject><subject>Peptides - chemistry</subject><subject>Phage-peptide library</subject><subject>Phospho-peptides</subject><subject>Phosphorylation</subject><subject>Protein Binding</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins - immunology</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Recombinant Proteins - metabolism</subject><subject>Serine - metabolism</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Tyrosine - metabolism</subject><issn>0196-9781</issn><issn>1873-5169</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkEtPWzEQRq2KCgLlJxR5hcrigh_3Ya8QivpAAnXRVsrOcsZjMErii-20or8ek0SwZDWLOd88DiGfOTvnjPcXvxjXfaMHxb8wccYYb4dm9oFMuBpk0_Fe75HJK3JADnN-YIy1rVb75IALqaTq1ITMpvc2WSiYwn9bQlzR6Gn5F-mIYwkOKY6hxBEzra1btxS1QhxTLBhWtNzbQq33CIWOnaQO75J1mzmfyEdvFxmPd_WI_Pn29ff0R3Pz8_v19OqmAdnz0ghtEZXs5NwJocDpwTvVtk56YMxZ7Ozct63QnQMBVqEEGCoGXjjsYQ7yiJxu59abHteYi1mGDLhY2BXGdTaD4EozrSvYbUFIMeeE3owpLG16MpyZF6Vmo9S8-DJMmI1SM6u5k92C9XyJ7i21c1iByy2A9c2_AZPJEHAF6EKqYoyL4Z0Vz3GsiKc</recordid><startdate>20021001</startdate><enddate>20021001</enddate><creator>Balass, M.</creator><creator>Kalef, E.</creator><creator>Maya, R.</creator><creator>Wilder, S.</creator><creator>Oren, M.</creator><creator>Katchalski-Katzir, E.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20021001</creationdate><title>Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation</title><author>Balass, M. ; Kalef, E. ; Maya, R. ; Wilder, S. ; Oren, M. ; Katchalski-Katzir, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-29aee8353bd228cd97fd844d3fc00dae5abf44295dc2ca8e3cc78cdcf2de6cbc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Anti-Mdm2 mAb2A10</topic><topic>Antibodies, Monoclonal - isolation &amp; purification</topic><topic>Antibodies, Monoclonal - metabolism</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Binding Sites</topic><topic>Epitope Mapping</topic><topic>Epitopes</topic><topic>Escherichia coli - genetics</topic><topic>Glutathione Transferase - metabolism</topic><topic>Humans</topic><topic>Mutation</topic><topic>Peptide epitopes</topic><topic>Peptide Fragments - chemistry</topic><topic>Peptide Fragments - genetics</topic><topic>Peptide Fragments - immunology</topic><topic>Peptide Fragments - metabolism</topic><topic>Peptides - chemistry</topic><topic>Phage-peptide library</topic><topic>Phospho-peptides</topic><topic>Phosphorylation</topic><topic>Protein Binding</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins - immunology</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Recombinant Proteins - metabolism</topic><topic>Serine - metabolism</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Tyrosine - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balass, M.</creatorcontrib><creatorcontrib>Kalef, E.</creatorcontrib><creatorcontrib>Maya, R.</creatorcontrib><creatorcontrib>Wilder, S.</creatorcontrib><creatorcontrib>Oren, M.</creatorcontrib><creatorcontrib>Katchalski-Katzir, E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Peptides (New York, N.Y. : 1980)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balass, M.</au><au>Kalef, E.</au><au>Maya, R.</au><au>Wilder, S.</au><au>Oren, M.</au><au>Katchalski-Katzir, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation</atitle><jtitle>Peptides (New York, N.Y. : 1980)</jtitle><addtitle>Peptides</addtitle><date>2002-10-01</date><risdate>2002</risdate><volume>23</volume><issue>10</issue><spage>1719</spage><epage>1725</epage><pages>1719-1725</pages><issn>0196-9781</issn><eissn>1873-5169</eissn><abstract>Phosphorylation of Mdm2, in response to DNA damage, resulted in prevention of p53 degradation in the cytoplasm as well as reduction of its binding with monoclonal antibody (mAb) 2A10. Using a 15-mer phage-peptide library, we identified two 2A10-epitopes on human Mdm2 (hdm2): at positions 255–266 (LDSEDYSLSEEG) and 389–400 (QESDDYSQPSTS). Synthetic peptides corresponding to the above sites, inhibit the binding of mAb2A10 to Mdm2 with high (4.5×10 −9 M) and moderate affinity (1.1×10 −7 M), respectively. Phospho-derivatives of these peptides, and of single human Mdm2 mutations S260D or S395D resulted in a considerable reduction in their binding with mAb2A10. These results provide a molecular explanation for the observation that reactivity of Mdm2 with mAb2A10 is inhibited by phosphorylation.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>12383858</pmid><doi>10.1016/S0196-9781(02)00147-X</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0196-9781
ispartof Peptides (New York, N.Y. : 1980), 2002-10, Vol.23 (10), p.1719-1725
issn 0196-9781
1873-5169
language eng
recordid cdi_proquest_miscellaneous_72189099
source MEDLINE; Elsevier ScienceDirect Journals
subjects Anti-Mdm2 mAb2A10
Antibodies, Monoclonal - isolation & purification
Antibodies, Monoclonal - metabolism
Antibodies, Monoclonal - pharmacology
Binding Sites
Epitope Mapping
Epitopes
Escherichia coli - genetics
Glutathione Transferase - metabolism
Humans
Mutation
Peptide epitopes
Peptide Fragments - chemistry
Peptide Fragments - genetics
Peptide Fragments - immunology
Peptide Fragments - metabolism
Peptides - chemistry
Phage-peptide library
Phospho-peptides
Phosphorylation
Protein Binding
Proto-Oncogene Proteins - genetics
Proto-Oncogene Proteins - immunology
Proto-Oncogene Proteins - metabolism
Recombinant Proteins - metabolism
Serine - metabolism
Tumor Suppressor Protein p53 - metabolism
Tyrosine - metabolism
title Characterization of two peptide epitopes on Mdm2 oncoprotein that affect p53 degradation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T15%3A54%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characterization%20of%20two%20peptide%20epitopes%20on%20Mdm2%20oncoprotein%20that%20affect%20p53%20degradation&rft.jtitle=Peptides%20(New%20York,%20N.Y.%20:%201980)&rft.au=Balass,%20M.&rft.date=2002-10-01&rft.volume=23&rft.issue=10&rft.spage=1719&rft.epage=1725&rft.pages=1719-1725&rft.issn=0196-9781&rft.eissn=1873-5169&rft_id=info:doi/10.1016/S0196-9781(02)00147-X&rft_dat=%3Cproquest_cross%3E72189099%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72189099&rft_id=info:pmid/12383858&rft_els_id=S019697810200147X&rfr_iscdi=true